Research ArticleCANCER
Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer
- View ORCID ProfileZhen Zhao*,
- View ORCID ProfileYuanke Li*,
- Hao Liu,
- Akshay Jain,
- Pratikkumar Vinodchandra Patel and
- View ORCID ProfileKun Cheng†
- Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
- ↵†Corresponding author. Email: chengkun{at}umkc.edu
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science Advances 15 Jul 2020:
Vol. 6, no. 29, eabb0616
DOI: 10.1126/sciadv.abb0616
Vol. 6, no. 29, eabb0616
DOI: 10.1126/sciadv.abb0616
Zhen Zhao
Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Yuanke Li
Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Hao Liu
Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Akshay Jain
Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Pratikkumar Vinodchandra Patel
Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Kun Cheng
Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.